Genetics CME

Credits: 1.00 CME
The Medical College of Wisconsin
Integrating Innovative Therapeutics With Allogeneic HCT in AML: Insights and Evidence From Induction to Maintenance
Alexander Perl, MD / James M. Foran, MD, FRCPC
29 March, 2019
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and Updated Guidelines: What Pathologists Need to Know and Do
Lynette Sholl, MD
6 February, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do
Lynette Sholl, MD
11 December, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Expert Insights on Available and Emerging Therapies for the Management of Pompe Disease
Loren del Mar Pena, MD, PhD
8 November, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Realizing the Potential of Precision Oncology in Lung Cancer—Challenges and Opportunities: Strengthening the Partnership Between Oncology and Pathology to Make the Most of the Latest Diagnostics and Therapies
Edward Garon, MD, MS
5 July, 2018
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Current and Novel Therapies in Improving Outcomes in Adults With PKU
14 June, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Diagnosing and Treating Acid Sphingomyelinase Deficiency: The Potential Impact of New Consensus Recommendations and Ongoing Clinical Trials of Emerging Therapies
Robin Lachmann, MD, PhD
25 May, 2018